Catawba Capital Management VA maintained its stake in shares of MetLife, Inc. (NYSE:MET) during the second quarter, Holdings Channel reports. The institutional investor owned 5,250 shares of the financial services provider’s stock at the end of the second quarter. Catawba Capital Management VA’s holdings in MetLife were worth $288,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in MET. Atria Investments LLC increased its stake in shares of MetLife by 2.6% in the first quarter. Atria Investments LLC now owns 18,914 shares of the financial services provider’s stock valued at $999,000 after buying an additional 488 shares in the last quarter. Prospera Financial Services Inc purchased a new stake in shares of MetLife during the first quarter valued at approximately $1,525,000. Tompkins Financial Corp increased its stake in shares of MetLife by 40.8% in the first quarter. Tompkins Financial Corp now owns 7,789 shares of the financial services provider’s stock valued at $342,000 after buying an additional 2,258 shares in the last quarter. Aberdeen Asset Management PLC UK increased its stake in shares of MetLife by 1.3% in the first quarter. Aberdeen Asset Management PLC UK now owns 469,645 shares of the financial services provider’s stock valued at $24,807,000 after buying an additional 6,188 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of MetLife by 4.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 393,208 shares of the financial services provider’s stock valued at $20,769,000 after buying an additional 15,716 shares in the last quarter. Institutional investors own 74.83% of the company’s stock.

Shares of MetLife, Inc. (NYSE MET) traded down 2.908% on Thursday, hitting $46.905. 2,065,114 shares of the company traded hands. MetLife, Inc. has a 1-year low of $35.21 and a 1-year high of $51.77. The firm’s 50 day moving average price is $48.79 and its 200-day moving average price is $47.33. The stock has a market capitalization of $49.85 billion, a price-to-earnings ratio of 551.823 and a beta of 1.46.

MetLife (NYSE:MET) last issued its quarterly earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The company had revenue of $17.39 billion during the quarter, compared to the consensus estimate of $17.11 billion. MetLife had a return on equity of 8.51% and a net margin of 0.30%. MetLife’s revenue was up 2.5% on a year-over-year basis. During the same period last year, the company earned $0.83 earnings per share. On average, equities research analysts expect that MetLife, Inc. will post $4.87 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 13th. Investors of record on Monday, August 7th will be given a $0.40 dividend. The ex-dividend date of this dividend is Thursday, August 3rd. This represents a $1.60 dividend on an annualized basis and a yield of 3.31%. MetLife’s dividend payout ratio is presently 1,777.98%.

ILLEGAL ACTIVITY WARNING: This piece was reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be viewed at https://www.dailypolitical.com/2017/08/10/metlife-inc-nysemet-position-maintained-by-catawba-capital-management-va.html.

A number of research firms recently issued reports on MET. TheStreet downgraded shares of MetLife from a “b-” rating to a “c” rating in a report on Tuesday, May 16th. Wells Fargo & Company restated a “buy” rating on shares of MetLife in a report on Saturday, July 1st. Argus decreased their price objective on shares of MetLife from $60.00 to $55.00 and set a “buy” rating for the company in a report on Wednesday. BidaskClub upgraded shares of MetLife from a “sell” rating to a “hold” rating in a report on Wednesday. Finally, Zacks Investment Research downgraded shares of MetLife from a “hold” rating to a “sell” rating in a report on Wednesday. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $59.10.

About MetLife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.